Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Autoimmune diseases, infections, use of antibiotics and the risk of acute myeloid leukaemia: a national population-based case-control study

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. How do we move towards a personalised approach in the treatment of Early Hodgkin lymphoma?

    Research output: Contribution to journalEditorialResearchpeer-review

  3. Outcome of relapse after allogeneic HSCT in children with ALL enrolled in the ALL-SCT 2003/2007 trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Evolution of relative survival for acute promyelocytic leukemia patients alive at landmark time-points: a population-based study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Eosinofili

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Associations between cohabitation status, treatment, and outcome in AML patients: a national population-based study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Stringent or nonstringent complete remission and prognosis in acute myeloid leukemia: a Danish population-based study

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Håndtering af hjertekomplikationer sekundært til medicinsk kræftbehandling

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Previous studies reported increased risk of acute myeloid leukaemia (AML) in individuals with inflammatory conditions. However, it is unclear whether this association is explained by preceding cytotoxic therapy or haematological diseases. We conducted a nationwide case-control study that included 3053 AML patients, diagnosed in Denmark between 2000 and 2013, and 30 530 sex- and age-matched population controls. We retrieved information on autoimmune disease, infections, and use of antibiotics and computed odds ratios for AML (conditional logistic regression). Results were stratified by AML type, sex, and age. Autoimmune diseases were associated with an overall increased risk of AML {odds ratio [OR] 1·3 [95% confidence interval (CI) = 1·1-1·5]}. However, the risk was confined to patients with previous haematological disease or cytotoxic therapy exposure [secondary/therapy-related AML (sAML/tAML0) OR 2·0 (95% CI = 1·6-2·6)] and not de novo AML [OR 1·1 (95% CI = 0·9-1·3)]. Similarly, any prior infection requiring hospitalization was associated with a higher risk of AML [OR 1·3 (95% CI = 1·1-1·4)]. Again, this association was evident for sAML/tAML [OR 1·8 (95% CI = 1·5-2·2)], and not de novo AML [OR 1·1 (95% CI = 1·0-1·2)]. In conclusion, autoimmune diseases and infections were associated with an increased AML risk only in subjects with prior haematological disease and/or cytotoxic treatment. These observations suggest, that inflammation plays - if any - a minor role for the development of de novo AML.

Original languageEnglish
JournalBritish Journal of Haematology
Volume181
Issue number2
Pages (from-to)205-214
Number of pages10
ISSN0007-1048
DOIs
Publication statusPublished - Apr 2018

    Research areas

  • Aged, Anti-Bacterial Agents/administration & dosage, Autoimmune Diseases/drug therapy, Case-Control Studies, Denmark/epidemiology, Female, Humans, Infection/drug therapy, Leukemia, Myeloid, Acute/chemically induced, Male, Middle Aged, Risk Factors

ID: 56684342